Intranasal insulin is administered instead of peripheral insulin to promote direct entry to the brain through the bulk flow, olfactory nerve channels, and trigeminal perivascular channels, avoiding the BBB limitations and potential hypoglycemia [34]. The gene discussed is INS; the disease is Hypoglycemia.